Table 1A.
Clinical information regarding thyroid disease for patients undergoing rectus muscle resection in Graves’ ophthalmopathy: History and treatments
| Case | Duration Graves’ disease, years |
Graves’ ophthalmopathy signs and symptoms |
Duration diplopia, years |
Radioactive iodine |
Corticosteroid treatments | Current thyroid medications | Smoking |
|---|---|---|---|---|---|---|---|
| Patients with restrictive strabismus | |||||||
| 1 | 7 | Proptosis OU | 6 | 5 yrs before resection | Pred, methylprednisolone 5–6 yrs bef resect | Levo | 20 pack-yr; quit 7 yrs before resection |
| 2 | 15 | Proptosis OU, increased IOP in upgaze, exposure keratopathy, upper lid retraction OU | 5 | None | Levo | Quit 5 yrs before resection | |
| 3 | 4 | Proptosis, lagophthalmos OU | >2 | None | Pred 2 yrs before resection and 1 yr before resection (after orbital decompression) | None; MMZ until 1 yr before resection | Quit 1 yr before resection |
| 4 | 2 | Proptosis, lid edema OU | 1.5 | 1.5 yrs before resection | None | Levo, MTX | |
| 5 | 5 | Inflammation treated with steroids, intermittent edema, bilat congestion | 2 | None | Oral and injected steroids 4–5 yrs before resection | MMZ | |
| Patients with nonrestrictive strabismus | |||||||
| 6 | 2 | Proptosis, upper lid retraction OU None | None | 2 mos before resection | None | PTU | 20 pack-yr; currently smokes one-half pack per day |
| 7 | 1 | None | 12 | None | None | MMZ | |
| 8 | 2 | Proptosis OU, tearing, eye pain, upper lid retraction OU | 1 | 2 yrs before resection | DXS × 2 mos 1 yr before resection | Levo, liothyronine | |
| Table 1B. Clinical information regarding thyroid disease for patients undergoing rectus muscle resection in Graves’ ophthalmopathy: visual acuity and ocular motility | |||||
|---|---|---|---|---|---|
| Preoperative ductions in field of action |
|||||
| Case | Visual acuity | Right eye | Left eye | ||
| Patients with restrictive strabismus | |||||
| 1 | OD 20/25 + 2 | −3 | −3 | −3 | −3 |
| OS 20/20 −3 | −1.5 | −2 | −1.5 | −1 | |
| −1 | −2 | −1 | −1 | ||
| 2 | OU 20/25 −2 | −3 | 0 | 0 | −4 |
| 0 | −3 | −1 | −3 | ||
| 0 | 0 | 0 | 0 | ||
| 3 | OU 20/30 | −1 | −1 | −1 | −1 |
| −1 | −1 | −2 | 0 | ||
| 0 | 0 | 0 | 0 | ||
| 4 | OD 20/25 + 2 | −2 | −2 | −2 | −2 |
| OS 20/40 | −3.5 | −0.5 | −0.5 | −3 | |
| −1 | −1 | −1 | −1 | ||
| 5 | OD 20/30 | 0 | 0 | +1 | 0 |
| OS 20/20 | 0 | −1 | 0 | 0 | |
| 0 | 0 | +1 | 0 | ||
| Patients with nonrestrictive strabismus | |||||
| 6 | OD NLP (childhood traumatic optic nerve atrophy) | −2 | +2 | +2 | 0 |
| 0 | −1 | −1 | 0 | ||
| OS 20/20 | 0 | +2 | +2 | 0 | |
| 7 | OU 20/20 | 0 | 0 | 0 | 0 |
| 0 | 0 | 0 | 0 | ||
| 0 | 0 | 0 | 0 | ||
| 8 | OU 20/20 | 0 | 0 | 0 | 0 |
| −3 | 0 | 0 | 0 | ||
| 0 | 0 | 0 | 0 | ||
DXS, dexamethasone; IOP, intraocular pressure; Levo, levothyroxine; MMZ, methimazole; MTX, methotrexate; OU, both eyes; pred, prednisone; PTU, propylthiouracil.
NLP, no light perception; OD, right eye; OS, left eye; OU, both eyes.